EXENDIN (9-39) Uses, Dosage, Side Effects and more
EXENDIN (9-39) is under investigation in clinical trial NCT02996812 (Evaluation of Single Ascending Doses of Subcutaneous Exendin 9-39 in Patients With Post-Bariatric Hypoglycemia).
| Attribute | Details |
|---|---|
| Trade Name | EXENDIN (9-39) |
| Generic | Avexitide |
| Avexitide Other Names | Avexitide, EXENDIN (9-39) |
| Type | |
| Formula | C149H234N40O47S |
| Weight | Average: 3369.8 Monoisotopic: 3367.687076009 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
